1 Knight R, Brazier M, Collins SJ. Human prion diseases: cause, clinical and diagnostic aspects. Contrib Microbiol. 2004;11:72–97.
2 Ritchie DL, Barria MA, Peden AH, Yull HM, Kirkpatrick J, Adlard P, Head MW, et al. UK Iatrogenic Creutzfeldt-Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approaches. Acta Neuropathol. 2017;133(4):579–95.
doi:10.1007/s00401-016-1638-x.
3 Dirzius E, Balnyte R, Steibliene V, Gleizniene R, Gudinaviciene I, Radziunas A, Petrikonis K. Sporadic Creutzfeldt-Jakob disease with unusual initial presentation as posterior reversible encephalopathy syndrome: a case report. BMC Neurol. 2016;16(1):234.
doi:10.1186/s12883-016-0751-8.
4 Pauri F, Amabile G, Fattapposta F, Pierallini A, Bianco F. Sporadic Creutzfeldt-Jakob disease without dementia at onset: clinical features, laboratory tests and sequential diffusion MRI (in an autopsy-proven case). Neurol Sci. 2004;25(4):234–7.
doi:10.1007/s10072-004-0328-y.
5 Alibhai J, Blanco RA, Barria MA, Piccardo P, Caughey B, Perry VH, Manson JC, et al. (2016). Distribution of Misfolded Prion Protein Seeding Activity Alone Does Not Predict Regions of Neurodegeneration. PLoS Biol. 2016;14(11):e1002579.
doi:10.1371/journal.pbio.1002579.
6 Zerr, I, Kallenberg K, Summers DM, et al. Brain. 2009;132:2659–68.